Bristol Myers, Takeda to pool data for AI-based drug discovery

Core Insights - Bristol Myers Squibb, Takeda Pharmaceuticals, and Astex Pharmaceuticals are collaborating to share proprietary data for the purpose of training an artificial intelligence model aimed at enhancing drug discovery and development [1] Company Collaboration - The partnership involves three major pharmaceutical companies, indicating a trend towards collaboration in the industry to leverage AI technology for drug development [1] AI in Drug Development - The initiative highlights the growing importance of artificial intelligence in the pharmaceutical sector, particularly in streamlining the drug discovery process [1]